ÂÜÀòÂÒÂ×

Richard Park has a diverse work experience in the pharmaceutical industry. Richard is currently working as a Senior Scientist at Cour Pharmaceuticals Development Company, Inc. since August 2021. Prior to this, from 2018 to 2021, they were an Independent Consultant/Contractor, serving as a Real Estate Developer.

From 2016 to 2018, Richard worked at Wockhardt USA as a Regulatory Affairs Assistant. Richard then joined Baxter International Inc. in 2013 as a Research Associate II, where they worked until 2016.

Before that, Richard worked at Adello Biologics, LLC (formerly Therapeutic Proteins International, LLC), from February 2013 to September 2013. Their responsibilities included the development, validation, and transfer of chromatographic methods for characterizing biologically produced interferons, cytokines, and monoclonal antibodies.

In 2012, Richard was employed as a Chemist at Fresenius Kabi, and from 2009 to 2012, they worked as a Chemist at Celgene (formerly Abraxis Bioscience, LLC). At Celgene, they were involved in in-process, final product, and stability testing of lyophilized oncology nanoparticles, as well as providing guidance to junior analysts and authoring training materials.

Overall, Richard Park has gained extensive experience in scientific research, regulatory affairs, and real estate development throughout their career in the pharmaceutical industry.

Richard Park attended Loyola University Chicago from 2004 to 2008. Richard obtained a Bachelor of Science (BS) degree in Chemistry during their time there.